Clinical Trials Directory

Trials / Completed

CompletedNCT02041208

Variability of Hemoglobin Levels After Kidney Transplantation

A Retrospective, Observational Study to Evaluate Hemoglobin Variability in Kidney Transplant Recipients With Chronic Renal Anemia.

Status
Completed
Phase
Study type
Observational
Enrollment
368 (actual)
Sponsor
Sociedad Española de Trasplante · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study es to determine hemoglobin variability in kidney transplant recipients with chronic renal anemia.

Detailed description

The primary endpoint of the study is hemoglobin level variability. For determination of this variability, the following patterns of hemoglobin level change will be established: * Target range hemoglobin (TRH): patients with hemoglobin values in the range of 11.0-12.0g/dl throughout the study period. * Low hemoglobin (LH): patients with levels below 11.0g/dl * High hemoglobin (HH): patients with levels above 12.0g/dl * Low-amplitude fluctuation with low hemoglobin (LALH): patients with at least one measurement of hemoglobin levels \<11.0g/dl and at least one measurement in the range of 11.0-12.0g/dl, but without hemoglobin measurements \>12.0g/dl. * Low-amplitude fluctuation with high hemoglobin (LAHH): patients with at least one measurement of hemoglobin levels \>12.0g/dl and at least one measurement in the range of 11.0-12.0g/dl, but without hemoglobin measurements \<11.0g/dl. * High-amplitude fluctuation (HAH): patients with at least one measurement of hemoglobin levels \<11.0g/dl and at least one measurement \>12.0g/dl. Secondary objectives: * To determine potential factors influencing hemoglobin variability. * To assess the influence of hemoglobin variability on cardiovascular risk of patients according to the REGICOR function at the end of the study period.

Conditions

Interventions

TypeNameDescription
PROCEDUREkidney transplantationkidney transplantation

Timeline

Start date
2012-03-01
Primary completion
2012-10-01
Completion
2012-10-01
First posted
2014-01-20
Last updated
2014-01-20

Locations

22 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT02041208. Inclusion in this directory is not an endorsement.